LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 1425

Search options

  1. Book ; Online: Influence of pesticide regulation on acute poisoning deaths in Sri Lanka / Darren M. Roberts . [et al.] ; Influence de la législation concernant les pesticides sur les décès par intoxication aiguë à Sri Lanka

    Roberts, Darren M / Karunarathna, Ayanthi / Buckley, Nick A / Manuweera, Gamini / Sheriff, M. H. Rezvi / Eddleston, Michael

    résumé ; Influencia de la regulación de los plaguicidas en las defunciones por intoxicación aguda en Sri Lanka : resumen

    2003  

    Abstract: Summaries in English, French, Spanish and ... ...

    Abstract Summaries in English, French, Spanish and Arabic
    Keywords Insecticides ; Endosulfan ; Poisoning ; Legislation ; Safety management ; Agriculture ; Sri Lanka ; Chemical Toxicology and Carcinogenicity ; poisoning supply and distribution ; mortality
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: Clinical outcomes associated with orphenadrine deliberate self-poisoning: a retrospective poisons centre study.

    Dhaliwal, Nina / Roberts, Darren M

    Clinical toxicology (Philadelphia, Pa.)

    2024  , Page(s) 1–6

    Abstract: Introduction: Orphenadrine overdoses can cause antimuscarinic toxicity, respiratory failure, refractory seizures and cardiotoxicity. The dose-toxicity relationship is poorly defined. Orphenadrine is marketed as immediate and sustained release ... ...

    Abstract Introduction: Orphenadrine overdoses can cause antimuscarinic toxicity, respiratory failure, refractory seizures and cardiotoxicity. The dose-toxicity relationship is poorly defined. Orphenadrine is marketed as immediate and sustained release formulations, and it is not known how the formulation impacts on toxicity. We determined the clinical toxicity of orphenadrine in patients referred to a regional poisons centre.
    Methods: Retrospective case series of patients in New South Wales with orphenadrine deliberate self-poisoning from January 2016 to April 2022 referred to the New South Wales Poisons Information Centre. Demographics, history of exposure, treatment and outcomes were extracted from clinical databases. Receiver-operating characteristic curves were constructed to determine thresholds predicting toxicity.
    Results: Forty-eight patients were identified, with information on clinical outcomes in 46 patients and doses in 41 patients. All patients were older than 12 years. The median orphenadrine dose was 770 mg (range 210-10,000 mg), 59 per cent as the immediate release formulation, and 67 per cent reported coingestants. Doses of sustained release formulations were significantly greater than immediate release formulations, median 2,750 mg versus 595 mg. Common clinical features were drowsiness (59 per cent), sinus tachycardia (37 per cent) and confusion (33 per cent). Three patients had mild hypotension, three were intubated for coma, and two had seizures; no patients suffered ventricular dysrhythmias. All patients survived, with 75 per cent being medically cleared within 24 hours of presentation. A dose-toxicity relationship was observed, but conclusions are limited by the small number of cases with moderate or severe toxicity.
    Discussion: All patients survived, and severe cardiac and neurological toxicity were not observed. This contrasts to published case reports noting severe poisoning at similar or lower doses. Formulation may have an impact on outcomes, with lesser toxicity from sustained release products.
    Conclusions: Orphenadrine doses up to 10 g were associated with antimuscarinic toxicity and sedation, but not severe cardiotoxicity. More research exploring the effect of dose and formulation on outcomes is required.
    Language English
    Publishing date 2024-03-25
    Publishing country England
    Document type Journal Article
    ZDB-ID 204476-6
    ISSN 1556-9519 ; 0009-9309 ; 0731-3810 ; 1556-3650
    ISSN (online) 1556-9519
    ISSN 0009-9309 ; 0731-3810 ; 1556-3650
    DOI 10.1080/15563650.2024.2323678
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Management of Poisonings and Intoxications.

    Ghannoum, Marc / Roberts, Darren M

    Clinical journal of the American Society of Nephrology : CJASN

    2023  Volume 18, Issue 9, Page(s) 1210–1221

    Abstract: Poisoning occurs after exposure to any of a number of substances, including medicines, which can result in severe toxicity including death. The nephrologist may be involved in poisonings that cause kidney disease and for targeted treatments. The overall ... ...

    Abstract Poisoning occurs after exposure to any of a number of substances, including medicines, which can result in severe toxicity including death. The nephrologist may be involved in poisonings that cause kidney disease and for targeted treatments. The overall approach to the poisoned patient involves the initial acute resuscitation and performing a risk assessment, whereby the exposure is considered in terms of the anticipated severity and in the context of the patient's status and treatments that may be required. Time-critical interventions such as gastrointestinal decontamination ( e.g. , activated charcoal) and antidotes are administered when indicated. The nephrologist is usually involved when elimination enhancement techniques are required, such as urine alkalinization or extracorporeal treatments. There is increasing data to guide decision making for the use of extracorporeal treatments in the poisoned patient. Principles to consider are clinical indications such as whether severe toxicity is present, anticipated, and/or will persist and whether the poison will be significantly removed by the extracorporeal treatment. Extracorporeal clearance is maximized for low-molecular weight drugs that are water soluble with minimal protein binding (<80%) and low endogenous clearance and volume of distribution. The dosage of some antidotes ( e.g. , N-acetylcysteine, ethanol, fomepizole) should be increased to maintain therapeutic concentrations once the extracorporeal treatment is initiated. To maximize the effect of an extracorporeal treatment, blood and effluent flows should be optimized, the filter with the largest surface area selected, and duration tailored to remove enough poison to reduce toxicity. Intermittent hemodialysis is recommended in most cases when an extracorporeal treatment is required because it is the most efficient, and continuous kidney replacement therapy is prescribed in some circumstances, particularly if intermittent hemodialysis is not readily available.
    MeSH term(s) Humans ; Antidotes/therapeutic use ; Charcoal/therapeutic use ; Acetylcysteine/therapeutic use ; Ethanol ; Poisons ; Poisoning/diagnosis ; Poisoning/therapy
    Chemical Substances Antidotes ; Charcoal (16291-96-6) ; Acetylcysteine (WYQ7N0BPYC) ; Ethanol (3K9958V90M) ; Poisons
    Language English
    Publishing date 2023-01-13
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2226665-3
    ISSN 1555-905X ; 1555-9041
    ISSN (online) 1555-905X
    ISSN 1555-9041
    DOI 10.2215/CJN.0000000000000057
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Responding to the rising number of suicides using barbiturates.

    Murnion, Bridin P / Roberts, Darren M

    The Medical journal of Australia

    2022  Volume 216, Issue 4, Page(s) 187–188

    MeSH term(s) Barbiturates ; Humans ; Suicide/prevention & control
    Chemical Substances Barbiturates
    Language English
    Publishing date 2022-02-04
    Publishing country Australia
    Document type Editorial ; Comment
    ZDB-ID 186082-3
    ISSN 1326-5377 ; 0025-729X
    ISSN (online) 1326-5377
    ISSN 0025-729X
    DOI 10.5694/mja2.51409
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Minoxidil overdose with hypotension effectively managed with norepinephrine, rather than dopamine.

    Chakar, Bashir / Salter, Mark / Roberts, Darren M

    Clinical toxicology (Philadelphia, Pa.)

    2023  Volume 61, Issue 2, Page(s) 133–134

    MeSH term(s) Humans ; Minoxidil/therapeutic use ; Dopamine/therapeutic use ; Norepinephrine/therapeutic use ; Hypotension/chemically induced ; Hypotension/drug therapy ; Vasodilator Agents ; Drug Overdose
    Chemical Substances Minoxidil (5965120SH1) ; Dopamine (VTD58H1Z2X) ; Norepinephrine (X4W3ENH1CV) ; Vasodilator Agents
    Language English
    Publishing date 2023-02-13
    Publishing country England
    Document type Letter
    ZDB-ID 204476-6
    ISSN 1556-9519 ; 0009-9309 ; 0731-3810 ; 1556-3650
    ISSN (online) 1556-9519
    ISSN 0009-9309 ; 0731-3810 ; 1556-3650
    DOI 10.1080/15563650.2022.2159831
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Expanding the evidence for managing metformin poisoning to support decision-making.

    Roberts, Darren M / Ghannoum, Marc

    Clinical toxicology (Philadelphia, Pa.)

    2022  Volume 61, Issue 4, Page(s) 203–206

    Abstract: Introduction: Metformin-associated lactic acidosis is a well-described and commonly encountered condition associated with significant morbidity and mortality. Patients with metformin-associated lactic acidosis are frequently managed in the intensive ... ...

    Abstract Introduction: Metformin-associated lactic acidosis is a well-described and commonly encountered condition associated with significant morbidity and mortality. Patients with metformin-associated lactic acidosis are frequently managed in the intensive care unit with supportive care, including volume resuscitation and consideration of an extracorporeal treatment to correct metabolic acidemia and remove metformin and lactate.
    Extracorporeal treatments in poisoning workgroup: The Extracorporeal Treatments in Poisoning Workgroup published evidence-based consensus recommendations in 2015 regarding the use of extracorporeal treatment in metformin toxicity. These recommendations list both clinical and biochemical indications, and they outline the rationale and evidence supporting each recommendation.
    New research since recommendations were published: Subsequent publications have provided new information regarding metformin-associated lactic acidosis and its treatment. A retrospective study showed that patients who did not meet the Extracorporeal Treatments in Poisoning Workgroup criteria for initiation of an extracorporeal treatment had a 100% survival. In patients who met the criteria, survival was approximately 75%; only 66% of these patients received an extracorporeal treatment, and this treatment did not appear to impact survival. Two other retrospective studies in patients diagnosed with metformin-associated lactic acidosis noted that extracorporeal treatments did not improve survival. However, those who received an extracorporeal treatment were more severely ill, potentially supporting a benefit from this intervention. A systematic review of patients receiving continuous kidney replacement therapy identified an overall survival that was higher than the overall survival in patients included in the Workgroup publication. This led the authors to suggest that intermittent hemodialysis may not be the preferred treatment for metformin toxicity. However, a closer look at the Workgroup data identified improved survival with each decade since the initial reports in the 1970s. Furthermore, there are multiple reports of persistent metformin-associated lactic acidosis that did not improve with standard continuous kidney replacement therapy, prompting an increase in the dosage of the extracorporeal treatment. The data supporting these observations are largely derived from retrospective studies, which have inherent biases, so prospective studies are required.
    Prescribing extracorporeal treatments for patients with metformin poisoning: Case-based decision-making is always necessary, but in general, we continue to follow the Extracorporeal Treatments in Poisoning Workgroup criteria because a convincing reason for changing these has not yet been presented. This includes the use of intermittent hemodialysis where possible, particularly in cases of severe poisoning. For patients with less severe poisoning or when intermittent hemodialysis is not readily available, it is reasonable to trial continuous modalities with careful observation for deterioration.
    MeSH term(s) Humans ; Retrospective Studies ; Acidosis, Lactic ; Metformin ; Drug Overdose/therapy ; Acidosis ; Renal Dialysis ; Poisoning/therapy ; Hypoglycemic Agents
    Chemical Substances Metformin (9100L32L2N) ; Hypoglycemic Agents
    Language English
    Publishing date 2022-08-05
    Publishing country England
    Document type Systematic Review ; Journal Article
    ZDB-ID 204476-6
    ISSN 1556-9519 ; 0009-9309 ; 0731-3810 ; 1556-3650
    ISSN (online) 1556-9519
    ISSN 0009-9309 ; 0731-3810 ; 1556-3650
    DOI 10.1080/15563650.2023.2196372
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Decision-making in suicide: When is the patient not for resuscitation?

    Bode, Matthew Jf / Huber, Jacqueline / Roberts, Darren M

    Emergency medicine Australasia : EMA

    2022  Volume 34, Issue 3, Page(s) 473–474

    MeSH term(s) Decision Making ; Humans ; Resuscitation ; Suicide/prevention & control
    Language English
    Publishing date 2022-04-06
    Publishing country Australia
    Document type Letter
    ZDB-ID 2161824-0
    ISSN 1742-6723 ; 1742-6731 ; 1035-6851
    ISSN (online) 1742-6723
    ISSN 1742-6731 ; 1035-6851
    DOI 10.1111/1742-6723.13977
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Estimating renal function for patients in wheelchairs.

    Beirne, Penny / Roberts, Darren M

    Australian prescriber

    2020  Volume 43, Issue 2, Page(s) 67

    Language English
    Publishing date 2020-04-01
    Publishing country Australia
    Document type Journal Article ; Comment
    ZDB-ID 1075442-8
    ISSN 0312-8008
    ISSN 0312-8008
    DOI 10.18773/austprescr.2020.020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Management of proteinuria: blockade of the renin-angiotensin-aldosterone system.

    Athavale, Akshay / Roberts, Darren M

    Australian prescriber

    2020  Volume 43, Issue 4, Page(s) 121–125

    Language English
    Publishing date 2020-08-03
    Publishing country Australia
    Document type Journal Article ; Review
    ZDB-ID 1075442-8
    ISSN 0312-8008
    ISSN 0312-8008
    DOI 10.18773/austprescr.2020.021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Poor relationship between N-terminal pro-brain natriuretic peptide (NT-proBNP) and level of consciousness following intentional ingestion of eucalyptus oil.

    Premachandra, Kulanka H / Roberts, Darren M

    Clinical toxicology (Philadelphia, Pa.)

    2021  Volume 59, Issue 11, Page(s) 1033–1034

    MeSH term(s) Consciousness ; Eating ; Eucalyptus Oil ; Humans ; Natriuretic Peptide, Brain ; Peptide Fragments
    Chemical Substances Peptide Fragments ; pro-brain natriuretic peptide (1-76) ; Natriuretic Peptide, Brain (114471-18-0) ; Eucalyptus Oil (2R04ONI662)
    Language English
    Publishing date 2021-03-01
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 204476-6
    ISSN 1556-9519 ; 0009-9309 ; 0731-3810 ; 1556-3650
    ISSN (online) 1556-9519
    ISSN 0009-9309 ; 0731-3810 ; 1556-3650
    DOI 10.1080/15563650.2021.1887884
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top